Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1995 Jun;71(6):1194–1198. doi: 10.1038/bjc.1995.232

S-phase specificity of cell killing by docetaxel (Taxotere) in synchronised HeLa cells.

C Hennequin 1, N Giocanti 1, V Favaudon 1
PMCID: PMC2033844  PMID: 7779710

Abstract

Cell viability following short (1 h) contact with paclitaxel or docetaxel was assayed using synchronised HeLa cells. Docetaxel proved almost totally lethal against S-phase cells. Its toxicity was only partial against cells in mitosis, and declined to a minimum with progression to G1. For paclitaxel, cytotoxicity increased with progression through S and G2, peaked at the time of mitosis, and decreased thereafter. Maximum resistance to paclitaxel was in early S. Although lethal, brief exposure to docetaxel in S-phase did not delay progression through S and G2. Gross damage was detectable immediately after mitosis, with dysfunction in cytokinesis and accumulation of multinucleated, non-viable cells. Arrest of cells at prometaphase required continuous contact with lethal amounts of docetaxel or reintroduction of drug shortly before mitosis following pulse-chase treatment in mid-S-phase. Paclitaxel at moderate doses presumably acts mostly via damage to the mitotic spindle. In contrast, the available data suggest that docetaxel primarily targets centrosome organisation, leading to abortive mitosis and cell death.

Full text

PDF
1194

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amin-Hanjani S., Wadsworth P. Inhibition of spindle elongation by taxol. Cell Motil Cytoskeleton. 1991;20(2):136–144. doi: 10.1002/cm.970200206. [DOI] [PubMed] [Google Scholar]
  2. Bissery M. C., Guénard D., Guéritte-Voegelein F., Lavelle F. Experimental antitumor activity of taxotere (RP 56976, NSC 628503), a taxol analogue. Cancer Res. 1991 Sep 15;51(18):4845–4852. [PubMed] [Google Scholar]
  3. Bjursell G., Reichard P. Effects of thymidine on deoxyribonucleoside triphosphate pools and deoxyribonucleic acid synthesis in Chinese hamster ovary cells. J Biol Chem. 1973 Jun 10;248(11):3904–3909. [PubMed] [Google Scholar]
  4. De Brabander M., Geuens G., Nuydens R., Willebrords R., De Mey J. Microtubule assembly in living cells after release from nocodazole block: the effects of metabolic inhibitors, taxol and PH. Cell Biol Int Rep. 1981 Sep;5(9):913–920. doi: 10.1016/0309-1651(81)90206-x. [DOI] [PubMed] [Google Scholar]
  5. De Brabander M., Geuens G., Nuydens R., Willebrords R., De Mey J. Taxol induces the assembly of free microtubules in living cells and blocks the organizing capacity of the centrosomes and kinetochores. Proc Natl Acad Sci U S A. 1981 Sep;78(9):5608–5612. doi: 10.1073/pnas.78.9.5608. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Donaldson K. L., Goolsby G. L., Wahl A. F. Cytotoxicity of the anticancer agents cisplatin and taxol during cell proliferation and the cell cycle. Int J Cancer. 1994 Jun 15;57(6):847–855. doi: 10.1002/ijc.2910570614. [DOI] [PubMed] [Google Scholar]
  7. Díaz J. F., Andreu J. M. Assembly of purified GDP-tubulin into microtubules induced by taxol and taxotere: reversibility, ligand stoichiometry, and competition. Biochemistry. 1993 Mar 23;32(11):2747–2755. doi: 10.1021/bi00062a003. [DOI] [PubMed] [Google Scholar]
  8. Extra J. M., Rousseau F., Bruno R., Clavel M., Le Bail N., Marty M. Phase I and pharmacokinetic study of Taxotere (RP 56976; NSC 628503) given as a short intravenous infusion. Cancer Res. 1993 Mar 1;53(5):1037–1042. [PubMed] [Google Scholar]
  9. Geard C. R., Jones J. M. Radiation and taxol effects on synchronized human cervical carcinoma cells. Int J Radiat Oncol Biol Phys. 1994 Jun 15;29(3):565–569. doi: 10.1016/0360-3016(94)90457-x. [DOI] [PubMed] [Google Scholar]
  10. Geuens G., de Brabander M., Nuydens R., De Mey J. The interaction between microtubules and intermediate filaments in cultured cells treated with taxol and nocodazole. Cell Biol Int Rep. 1983 Jan;7(1):35–47. doi: 10.1016/0309-1651(83)90103-0. [DOI] [PubMed] [Google Scholar]
  11. Green K. J., Goldman R. D. The effects of taxol on cytoskeletal components in cultured fibroblasts and epithelial cells. Cell Motil. 1983;3(4):283–305. doi: 10.1002/cm.970030402. [DOI] [PubMed] [Google Scholar]
  12. Gupta R. S. Species-specific differences in toxicity of antimitotic agents toward cultured mammalian cells. J Natl Cancer Inst. 1985 Jan;74(1):159–164. [PubMed] [Google Scholar]
  13. Guéritte-Voegelein F., Guénard D., Lavelle F., Le Goff M. T., Mangatal L., Potier P. Relationships between the structure of taxol analogues and their antimitotic activity. J Med Chem. 1991 Mar;34(3):992–998. doi: 10.1021/jm00107a017. [DOI] [PubMed] [Google Scholar]
  14. Hanauske A. R., Degen D., Hilsenbeck S. G., Bissery M. C., Von Hoff D. D. Effects of Taxotere and taxol on in vitro colony formation of freshly explanted human tumor cells. Anticancer Drugs. 1992 Apr;3(2):121–124. doi: 10.1097/00001813-199204000-00008. [DOI] [PubMed] [Google Scholar]
  15. Hennequin C., Giocanti N., Balosso J., Favaudon V. Interaction of ionizing radiation with the topoisomerase I poison camptothecin in growing V-79 and HeLa cells. Cancer Res. 1994 Apr 1;54(7):1720–1728. [PubMed] [Google Scholar]
  16. Horwitz S. B. Mechanism of action of taxol. Trends Pharmacol Sci. 1992 Apr;13(4):134–136. doi: 10.1016/0165-6147(92)90048-b. [DOI] [PubMed] [Google Scholar]
  17. Jordan M. A., Thrower D., Wilson L. Mechanism of inhibition of cell proliferation by Vinca alkaloids. Cancer Res. 1991 Apr 15;51(8):2212–2222. [PubMed] [Google Scholar]
  18. Jordan M. A., Toso R. J., Thrower D., Wilson L. Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations. Proc Natl Acad Sci U S A. 1993 Oct 15;90(20):9552–9556. doi: 10.1073/pnas.90.20.9552. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Kelland L. R., Abel G. Comparative in vitro cytotoxicity of taxol and Taxotere against cisplatin-sensitive and -resistant human ovarian carcinoma cell lines. Cancer Chemother Pharmacol. 1992;30(6):444–450. doi: 10.1007/BF00685595. [DOI] [PubMed] [Google Scholar]
  20. Kuriyama R., Borisy G. G. Centriole cycle in Chinese hamster ovary cells as determined by whole-mount electron microscopy. J Cell Biol. 1981 Dec;91(3 Pt 1):814–821. doi: 10.1083/jcb.91.3.814. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Long B. H., Fairchild C. R. Paclitaxel inhibits progression of mitotic cells to G1 phase by interference with spindle formation without affecting other microtubule functions during anaphase and telephase. Cancer Res. 1994 Aug 15;54(16):4355–4361. [PubMed] [Google Scholar]
  22. Lopes N. M., Adams E. G., Pitts T. W., Bhuyan B. K. Cell kill kinetics and cell cycle effects of taxol on human and hamster ovarian cell lines. Cancer Chemother Pharmacol. 1993;32(3):235–242. doi: 10.1007/BF00685842. [DOI] [PubMed] [Google Scholar]
  23. Madoc-Jones H., Mauro F. Interphase action of vinblastine and vincristine: differences in their lethal action through the mitotic cycle of cultured mammalian cells. J Cell Physiol. 1968 Dec;72(3):185–196. doi: 10.1002/jcp.1040720306. [DOI] [PubMed] [Google Scholar]
  24. Na G. C., Timasheff S. N. In vitro vinblastine-induced tubulin paracrystals. J Biol Chem. 1982 Sep 10;257(17):10387–10391. [PubMed] [Google Scholar]
  25. Parness J., Horwitz S. B. Taxol binds to polymerized tubulin in vitro. J Cell Biol. 1981 Nov;91(2 Pt 1):479–487. doi: 10.1083/jcb.91.2.479. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Prakash V., Timasheff S. N. The interaction of vincristine with calf brain tubulin. J Biol Chem. 1983 Feb 10;258(3):1689–1697. [PubMed] [Google Scholar]
  27. Ringel I., Horwitz S. B. Studies with RP 56976 (taxotere): a semisynthetic analogue of taxol. J Natl Cancer Inst. 1991 Feb 20;83(4):288–291. doi: 10.1093/jnci/83.4.288. [DOI] [PubMed] [Google Scholar]
  28. Riou J. F., Naudin A., Lavelle F. Effects of Taxotere on murine and human tumor cell lines. Biochem Biophys Res Commun. 1992 Aug 31;187(1):164–170. doi: 10.1016/s0006-291x(05)81474-3. [DOI] [PubMed] [Google Scholar]
  29. Robbins E., Jentzsch G., Micali A. The centriole cycle in synchronized HeLa cells. J Cell Biol. 1968 Feb;36(2):329–339. doi: 10.1083/jcb.36.2.329. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Roberts J. R., Allison D. C., Donehower R. C., Rowinsky E. K. Development of polyploidization in taxol-resistant human leukemia cells in vitro. Cancer Res. 1990 Feb 1;50(3):710–716. [PubMed] [Google Scholar]
  31. Roberts J. R., Rowinsky E. K., Donehower R. C., Robertson J., Allison D. C. Demonstration of the cell cycle positions of taxol-induced "asters" and "bundles" by sequential measurements of tubulin immunofluorescence, DNA content, and autoradiographic labeling of taxol-sensitive and -resistant cells. J Histochem Cytochem. 1989 Nov;37(11):1659–1665. doi: 10.1177/37.11.2572626. [DOI] [PubMed] [Google Scholar]
  32. Rowinsky E. K., Donehower R. C., Jones R. J., Tucker R. W. Microtubule changes and cytotoxicity in leukemic cell lines treated with taxol. Cancer Res. 1988 Jul 15;48(14):4093–4100. [PubMed] [Google Scholar]
  33. Rowinsky E. K., Onetto N., Canetta R. M., Arbuck S. G. Taxol: the first of the taxanes, an important new class of antitumor agents. Semin Oncol. 1992 Dec;19(6):646–662. [PubMed] [Google Scholar]
  34. Schiff P. B., Fant J., Horwitz S. B. Promotion of microtubule assembly in vitro by taxol. Nature. 1979 Feb 22;277(5698):665–667. doi: 10.1038/277665a0. [DOI] [PubMed] [Google Scholar]
  35. Schiff P. B., Horwitz S. B. Taxol assembles tubulin in the absence of exogenous guanosine 5'-triphosphate or microtubule-associated proteins. Biochemistry. 1981 May 26;20(11):3247–3252. doi: 10.1021/bi00514a041. [DOI] [PubMed] [Google Scholar]
  36. Schiff P. B., Horwitz S. B. Taxol stabilizes microtubules in mouse fibroblast cells. Proc Natl Acad Sci U S A. 1980 Mar;77(3):1561–1565. doi: 10.1073/pnas.77.3.1561. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Skoda R. C., Jaussi R., Christen P. Vinblastine inhibits the maturation of the precursor of mitochondrial aspartate aminotransferase. Vincristine and six other cytoskeleton inhibitors do not show this effect. Biochem Biophys Res Commun. 1983 Aug 30;115(1):144–152. doi: 10.1016/0006-291x(83)90981-6. [DOI] [PubMed] [Google Scholar]
  38. Tsao Y. P., D'Arpa P., Liu L. F. The involvement of active DNA synthesis in camptothecin-induced G2 arrest: altered regulation of p34cdc2/cyclin B. Cancer Res. 1992 Apr 1;52(7):1823–1829. [PubMed] [Google Scholar]
  39. Wani M. C., Taylor H. L., Wall M. E., Coggon P., McPhail A. T. Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. J Am Chem Soc. 1971 May 5;93(9):2325–2327. doi: 10.1021/ja00738a045. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES